Keystone eSymposia Logo

Joint meeting with Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics

NeuroImmune Interactions in Health and Disease

June 7-9, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


The emerging field of neuroimmunology is one of the most exciting and fastest moving areas in biomedical research. Communication between the brain and the immune system play critical roles in neural development, homeostasis and disease. Emerging human genetics implicate innate and adaptive immune pathways in many neurological diseases; however, the disease mechanisms remain elusive. Intersections between the nervous and immune systems are complex and can have both beneficial and detrimental impact on brain function depending on the context. It is thus crucial that we understand the mechanisms that give rise to these divergent outcomes. The extraordinary depth and breadth of science is emphasized by the program and includes topics such as peripheral immunity, inflammation, and interactions between the brain and the periphery, microglia function and dysfunction, microbiome and gut-brain axis, immune mechanisms of synapse loss in development and disease, mechanisms of neuroimmune communication at brain borders, and glymphatic-lymphatic connections. The program will also include several workshops on new discoveries, tools and approaches to analyze and integrate big-data (omics) aspects of neuroimmunology research, and to model neural-immune signaling in different contexts, including human disease. 

This conference will bring together an interdisciplinary group of scientists to discuss these and other emerging topics in neuroimmunology, with emphasis on the mechanisms underlying neural-immune crosstalk in health and disease. A major goal is to cultivate cross-disciplinary research by bringing together cutting-edge researchers that represent the entire spectrum of the field, from pure neuroscience to pure immunology, with the emerging field of neuroimmunology in between them. The conference will also provide opportunities for outstanding senior leaders to inspire young scientists in the field to move in innovative directions.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSNeuroImmune21




Program Details



Keynote Speakers


22e10814e407d6aa9b68f3341e0517fa.png

Christopher K. Glass, MD, PhD
University of California, San Diego


331e656125c723b9f72b8f265c5831da.png

Akiko Iwasaki, PhD
HHMI/Yale University School of Medicine



Speaking at this eSymposia


Burkhard Becher

University of Zurich, Switzerland


Gloria Choi

Massachusetts Institute of Technology, USA


Marco Colonna

Washington University School of Medicine, USA


Richard Daneman

University of California, San Diego, USA


Betty Diamond

Feinstein Institute for Medical Research, USA


Anthony J. Filiano

Duke University, USA


Sonia Garel

INSERM, France


Christopher K. Glass

University of California, San Diego, USA


Jonathan P. Godbout

Ohio State University, USA


David M. Holtzman

Washington University, USA


Elaine Y. Hsiao

University of California, Los Angeles, USA


Akiko Iwasaki

HHMI/Yale University School of Medicine, USA


Brian Kim

Washington University School of Medicine, USA


Jonathan Kipnis

Washington University School of Medicine, USA


Holly Kordasiewicz

Ionis Pharmaceuticals, USA


Maria Lehtinen

Harvard Medical School, USA


Joseph W. Lewcock

Denali Therapeutics, USA


Shane Antony Liddelow

New York University Langone Medical Center, USA


Johan Luthman

Lundbeck, Denmark


Daniel Mucida

Rockefeller University, USA


Maiken Nedergaard

University of Rochester, USA


Francisco J. Quintana

Harvard Medical School, USA


Dorothy Schafer

University of Massachusetts Medical School, USA


Michal Schwartz

Weizmann Institute of Science, Israel


Beth Stevens

Boston Children's Hospital, Harvard Medical School, USA


Henrique Veiga-Fernandes

Champalimaud Research, Portugal


Frauke Zipp

Johannes-Gutenberg-Universität Mainz, Germany






Sponsors


sponsor-carousel-biolegend.png

Sponsor-Carousel-cell-research-red.png

Sponsor-Carousel-Synthego.png

 

sponsor-carousel-ultragenyx.png

 




Additional Support



 

sponsor-carousel-NanoString.png

 

Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

Sponsor-Carousel-StemCell-Technologies.png

sponsor-carousel-scientist.png





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia